Phoenix Biotech Acquisition Corp. PBAXU NASDAQ

NASDAQ Global Market • Financial Services • Shell Companies • US • USD

There have been 16 recent insider transactions recorded for Phoenix Biotech Acquisition Corp. (PBAXU), including 8 buys and 1 sell. Total insider buying was valued at $479.92K and total insider selling at $3.81M.

Notable insiders with recent activity include Laporte Kathleen, Atwood Brian G, Ehrlich Christopher B. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.

Insider Transactions — PBAXU

Date	Name	Role	Transaction	Shares	Avg. Price	Value	Shares Owned
2021-10-08	Laporte Kathleen	Director	Other (Buy)	17,500	-	-	17,500
2021-10-08	Atwood Brian G	Director	Other (Buy)	25,000	-	-	25,000
2021-10-08	Ehrlich Christopher B	10 Percent Owner, Officer: CEO and Secretary	Other (Buy)	18,366	$11.50	$211.21K	349,998
2021-10-08	Geffken Daniel E.	Chief Financial Officer	Other (Buy)	30,000	-	-	30,000
2021-10-08	Loewy Caroline M	Director	Other (Buy)	17,500	-	-	17,500
2021-10-08	Fisher Douglas	President	Other (Buy)	5,000	$11.50	$57.5K	5,000
2021-10-08	Kosacz Barbara	Director	Other (Buy)	17,500	-	-	17,500
2021-10-08	Phoenix Biotech Sponsor, Llc	10 Percent Owner	Other (Buy)	18,366	$11.50	$211.21K	349,998
2021-10-05	Laporte Kathleen	Director	Unknown	-	-	-	-
2021-10-05	Atwood Brian G	Director	Unknown	-	-	-	-
2021-10-05	Ehrlich Christopher B	10 Percent Owner, Officer: CEO and And Secretary	Unknown	331,632	$11.50	$3.81M	-
2021-10-05	Geffken Daniel E.	Officer	Unknown	-	-	-	-
2021-10-05	Loewy Caroline M	Director	Unknown	-	-	-	-
2021-10-05	Fisher Douglas	Officer	Unknown	-	-	-	-
2021-10-05	Kosacz Barbara	Director	Unknown	-	-	-	-
2021-10-05	Phoenix Biotech Sponsor, Llc	10 Percent Owner	Disposition	331,632	$11.50	$3.81M	-

■ Informative Buy/Sell — open market transaction (most significant) ■ Uninformative Buy — award, option exercise, conversion ■ Uninformative Sell — tax withholding, award vest sale ■ Neutral — gift, trust, expiry